Executive Summary
The August 14, 2026, filings reveal a robust wave of sector consolidation across India, with 19 filings showing a clear trend of companies streamlining structures, acquiring minority stakes, and expanding into adjacent verticals.
Key themes include the finalization of multi-year acquisitions (Greaves Cotton, Physicswallah), procedural mergers of wholly-owned subsidiaries (NHPC, Spandana Sphoorty, Zensar), and strategic greenfield expansions into new geographies (Gufic Biosciences, Jupiter Infomedia). A significant change in control at Parmax Pharma (acquirer group stake rising from 27.20% to 58.01%) and the listing of merged entity shares (Aster DM Quality Care) mark major milestones. Financially, the period comparisons show a mixed picture: Orchid Pharma's full-year consolidated profit plunged 92.6% YoY post-amalgamation, while Race Eco Chain's subsidiary showed explosive revenue growth from a low base. Insider activity is limited but notable with the resignation and immediate reappointment of a director at Spandana Sphoorty. The most critical development is the Adani Energy Solutions acquisition of Vizag Power Transmission, linked to a massive ₹8,500 crore transmission project, signaling large-scale infrastructure consolidation. Portfolio-level patterns indicate a preference for vertical integration (20 Microns, Greaves Cotton) and cost-synergy-driven amalgamations (Spandana Sphoorty, GB Global).
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: M&A · Insider trading
Tracking the trend? Catch up on the prior India Sector Consolidation Regulatory Filings digest from August 13, 2026.
Investment Signals (10)
- Greaves Cotton ↓ (BULLISH)▲
Completed the final tranche of its multi-year acquisition of Excel Controlinkage, making it a wholly owned subsidiary. Excel's revenue grew from ₹105 Cr (FY2020) to ₹167 Cr (FY2022), indicating strong organic growth. The acquisition at a pre-agreed valuation matrix suggests disciplined capital allocation.
- Race Eco Chain ↓ (BULLISH)▲
Subsidiary Ganesha Recycling Chain's turnover surged from 0.01 Lakh (2025) to 21.19 Lakh (2026), showing exponential growth from a low base. The ₹1.02 Cr rights investment maintains 51% stake, positioning the company for recycling sector growth.
- Adani Energy Solutions ↓ (BULLISH)▲
Acquired 100% of Vizag Power Transmission for face value (₹10/share), linked to a ~₹8,500 Cr transmission project for 4,500 MW green hydrogen demand. This low-cost entry into a high-value infrastructure project is a major growth catalyst.
- Orchid Pharma ↓ (MIXED)▲
Post-amalgamation of Dhanuka Laboratories, standalone Q4 FY26 profit swung from a loss of ₹254.55 Lakh (Q3 FY26) to a profit of ₹3,266.29 Lakh, a massive sequential turnaround. However, full-year FY26 profit fell 75.6% YoY, indicating integration challenges.
- Parmax Pharma ↓ (BULLISH)▲
Acquirers increased stake from 27.20% to 58.01% (30.81% acquired) at ₹35/share, gaining majority control. This change in control at a low price could signal a turnaround or value unlocking.
- Info Edge ↓ (MIXED)▲
Invested ₹8.90 Cr for 18.58% in Factrika (on-demand industrial workforce platform) with potential to reach ~26% by March 2027. Factrika's FY26 turnover of ₹3.69 Cr vs. net loss of ₹2.09 Cr shows early-stage but high-growth potential.
- 20 Microns ↓ (MIXED)▲
Acquired 99.99% stake in Shree Shrest Minerals for ₹1.5 Cr, gaining mining rights for Quartz and Feldspar. The target has been loss-making (net loss of ₹3,01,205 in FY2025), but the strategic value of captive sourcing could improve margins.
- Indian Card Clothing ↓ (MIXED)▲
Q1 FY27 standalone revenue declined 5.4% YoY, but total income rose 14.9% YoY due to a 40.5% surge in other income. The £250,000 investment in UK subsidiary Garnett Wire (turnover growing from £738,701 in FY24 to £826,760 in FY26) shows international expansion.
- Gufic Biosciences ↓ (BULLISH)▲
Approved incorporation of a Philippines subsidiary with USD 250,000 investment for pharma marketing and distribution. This expands geographic footprint into a high-growth ASEAN market.
- Aster DM Quality Care (BULLISH)▲
Received trading approval for 35.35 Cr shares allotted under the merger with Quality Care India, effective August 17, 2026. This unlocks liquidity and marks the completion of a major hospital consolidation.
Risk Flags (10)
- Orchid Pharma↓ [HIGH RISK]▼
Full-year FY26 consolidated profit plunged 92.6% YoY (from ₹13,507.05 Lakh to ₹995.91 Lakh), with statutory auditors issuing a modified opinion on consolidated results. This signals severe post-merger integration risks and potential accounting irregularities.
- 20 Microns↓ [MEDIUM RISK]▼
Acquired a loss-making mining firm (net loss of ₹3,01,205 in FY2025) with declining turnover. The ₹1.5 Cr acquisition could become a drag on profitability if captive sourcing benefits do not materialize.
- Info Edge↓ [MEDIUM RISK]▼
Investment in Factrika (FY26 net loss of ₹2.09 Cr on turnover of ₹3.69 Cr) and SIHL (zero revenue for three years) carries high execution risk. The second tranche is conditional on performance milestones, indicating uncertainty.
- Physicswallah↓ [LOW RISK]▼
Acquired remaining 10% of BIGPL, which has minimal turnover (₹0.16 Cr in FY26) and negative net worth of ₹(66,90,740). The zero-cash consideration suggests limited value, but the entity could be a liability.
- Indian Card Clothing↓ [MEDIUM RISK]▼
CFO Sanjeevkumar Karkamkar resigned effective September 1, 2026, citing advancing age. While he remains a Non-Executive Director, the loss of a key financial executive could create temporary instability.
- GB Global↓ [MEDIUM RISK]▼
NCLT-approved merger with Dev Land and Housing provides exit at ₹120/share + redeemable preference shares, but shares have been suspended since June 2021. Shareholders face illiquidity and a complex payout structure.
- Spandana Sphoorty↓ [MEDIUM RISK]▼
The amalgamation of Criss Financial is subject to multiple approvals (NCLT, RBI, shareholders, creditors), creating regulatory and timeline risk. The resignation of nominee director Neeraj Swaroop (Kedaara Capital) followed by his immediate appointment as Independent Director raises governance questions.
- NHPC↓ [LOW RISK]▼
The amalgamation of Jalpower Corporation is a procedural step with no material financial impact, but the hearing on August 25, 2026, could face objections.
- Race Eco Chain↓ [LOW RISK]▼
The subsidiary Ganesha Recycling Chain's turnover grew from 0.01 Lakh to 21.19 Lakh, but from an extremely low base. The absolute revenue is still negligible, and scalability is unproven.
- Parmax Pharma↓ [MEDIUM RISK]▼
The 30.81% stake acquisition at ₹35/share is off-market and shares are yet to be credited to demat accounts. Any delay or dispute in settlement could create uncertainty.
Opportunities (10)
- Adani Energy Solutions↓ (OPPORTUNITY)◆
Acquisition of Vizag Power Transmission at face value (₹10/share) provides a low-cost entry into a ₹8,500 Cr transmission project catering to 4,500 MW green hydrogen demand. This aligns with India's renewable energy push and could generate significant long-term returns.
- Greaves Cotton↓ (OPPORTUNITY)◆
Excel Controlinkage, now a wholly owned subsidiary, is the margin leader in motion control systems. With revenue growing from ₹105 Cr (FY2020) to ₹167 Cr (FY2022), full ownership allows for margin accretion and cross-selling into Greaves' OEM network.
- Aster DM Quality Care (OPPORTUNITY)◆
Listing of 35.35 Cr shares on August 17, 2026, provides liquidity event post-merger with Quality Care India (CARE Hospitals). The combined entity is a top-5 hospital chain, and the stock could re-rate as synergies materialize.
- Parmax Pharma↓ (OPPORTUNITY)◆
Change in control with acquirers holding 58.01% at ₹35/share could lead to a turnaround or strategic restructuring. If the new management unlocks value, the stock could see significant upside from current levels.
- Orchid Pharma↓ (OPPORTUNITY)◆
Despite full-year profit decline, the Q4 FY26 standalone profit of ₹3,266.29 Lakh (vs. Q3 loss of ₹254.55 Lakh) shows a sharp sequential recovery. If the Dhanuka Laboratories integration stabilizes, FY27 could see a strong rebound.
- Gufic Biosciences↓ (OPPORTUNITY)◆
Expansion into the Philippines with a wholly-owned subsidiary for pharma marketing and distribution opens a new high-growth market. The USD 250,000 investment is modest, but the strategic value of direct market access is significant.
- Race Eco Chain↓ (OPPORTUNITY)◆
The subsidiary Ganesha Recycling Chain's 2,118x revenue growth (0.01 Lakh to 21.19 Lakh) indicates strong early traction in the recycling sector. If this growth sustains, the ₹1.02 Cr investment could yield high returns.
- Indian Card Clothing↓ (OPPORTUNITY)◆
The UK subsidiary Garnett Wire's turnover grew from £738,701 (FY24) to £826,760 (FY26), showing consistent growth. The additional £250,000 investment could accelerate international expansion and diversify revenue.
- 20 Microns↓ (OPPORTUNITY)◆
Captive sourcing of Quartz and Feldspar through the Shree Shrest Minerals acquisition could reduce raw material costs and improve margins over time. The ₹1.5 Cr acquisition cost is minimal relative to potential savings.
- Spandana Sphoorty↓ (OPPORTUNITY)◆
The amalgamation of Criss Financial aims to reduce duplicity of costs and achieve revenue synergies. With no change in shareholding pattern, existing shareholders benefit from cost savings and simplified structure.
Sector Themes (6)
- Vertical Integration in Industrial Minerals◆
20 Microns' acquisition of Shree Shrest Minerals for captive Quartz and Feldspar sourcing, combined with Greaves Cotton's full ownership of Excel Controlinkage (motion control systems), shows a clear trend of companies securing upstream supply chains to improve margins and reduce dependency. This is particularly relevant for commodity-sensitive sectors.
- Hospital Sector Consolidation Nearing Completion◆
Aster DM's merger with Quality Care India (CARE Hospitals) is now operational with share listing, creating a top-5 hospital chain. This follows a wave of consolidation in Indian healthcare, with Rainbow Children's Medicare also acquiring a 64% stake in Super Prime Medical Care LLP. The sector is becoming more concentrated, benefiting large players with scale.
- Amalgamation of Wholly-Owned Subsidiaries for Cost Synergies◆
Multiple filings (NHPC-JPCL, Spandana Sphoorty-Criss Financial, Zensar-M3BI/Bridgeview, GB Global-Dev Land) involve merging wholly-owned subsidiaries into parents. This trend is driven by regulatory simplification, cost reduction, and improved capital efficiency, particularly in financial services and infrastructure.
- Early-Stage Venture Investments by Cash-Rich Companies◆
Info Edge's investment in Factrika (on-demand industrial workforce platform) and Race Eco Chain's rights issue in Ganesha Recycling Chain highlight a pattern of established companies making small, strategic bets in high-growth, early-stage ventures. These investments carry high risk but offer asymmetric upside if successful.
- Geographic Expansion into High-Growth ASEAN Markets◆
Gufic Biosciences' Philippines subsidiary and Jupiter Infomedia's UAE subsidiary (Arix Metals Trading FZCO) indicate a growing trend of Indian companies establishing direct presence in Southeast Asia and the Middle East to capture demand in pharmaceuticals and metals trading. This reduces reliance on third-party distributors.
- Infrastructure-Led Transmission Consolidation◆
Adani Energy Solutions' acquisition of Vizag Power Transmission, linked to a ₹8,500 Cr green hydrogen project, signals a strategic push to consolidate power transmission infrastructure to support renewable energy goals. This could trigger further M&A in the transmission sector as other players seek similar opportunities.
Watch List (8)
- 👁
Hearing for amalgamation of Jalpower Corporation before MCA on August 25, 2026. Watch for any objections or delays that could impact the timeline. [August 25, 2026]
- Aster DM Quality Care👁
Listing of 35.35 Cr shares on August 17, 2026. Monitor trading volume and price action to gauge market reception of the merged entity. [August 17, 2026]
-
Crediting of 11,52,450 shares to acquirers' demat accounts. Any delay could signal disputes. Also watch for open offer obligations if triggered. [Ongoing]
-
Q1 FY27 results (due by mid-August 2026) will be the first full quarter post-Dhanuka Laboratories amalgamation. Watch for revenue synergy realization and margin improvement. [Mid-August 2026]
-
Second tranche investment in Factrika is conditional on performance milestones by March 31, 2027. Monitor Factrika's revenue growth and path to profitability. [March 31, 2027]
-
NCLT and RBI approvals for Criss Financial amalgamation. Any regulatory pushback could delay cost synergies. Also watch for Neeraj Swaroop's role as Independent Director. [Ongoing]
-
Execution of the ₹8,500 Cr transmission project in Andhra Pradesh. Any delays or cost overruns could impact returns. Also watch for further transmission asset acquisitions. [Ongoing]
-
Incorporation of Philippines subsidiary within 12 months. Monitor regulatory approvals and initial operational setup. [August 2027]
Filing Analyses
(19)
14-08-2026
Greaves Cotton Limited has completed the final tranche of its multi-year acquisition of Excel Controlinkage Private Limited, acquiring the remaining 20% stake via secondary purchase effective August 13, 2026, making Excel a wholly owned subsidiary. The total enterprise value for the initial 60% stake was capped at ₹3,850 million, with subsequent tranches at a pre-agreed valuation matrix. Excel, a leading motion control systems manufacturer, reported revenue growth from ₹105 Cr (FY2020) to ₹167 Cr (FY2022), though the filing does not provide financials for the intervening years or the current period.
- · The acquisition was executed under a definitive agreement dated April 6, 2023, with the final tranche completed by August 2026 as originally planned.
- · Excel Controlinkage was incorporated on April 20, 1994, and is described as the margin leader in the motion control systems industry.
- · The company serves OEMs and aftermarket across Commercial Vehicles, Construction Equipment, Agriculture, Material Handling, Marine, and SPVs.
- · No governmental or regulatory approvals were required for the acquisition.
- · The consideration was entirely cash; no share swap was involved.
- · The shares were credited to Greaves Cotton's demat account on August 13, 2026, with confirmation received on August 14, 2026.
14-08-2026
Info Edge (India) Limited has approved two investments: a ₹8.90 Crore first tranche investment in Udyogtech Ventures Private Limited (Factrika) for an 18.58% stake, with a potential second tranche to reach ~26% by March 31, 2027, and a ₹90 Crore investment in its wholly owned subsidiary Startup Investments (Holding) Limited (SIHL). Factrika is an early-stage on-demand industrial workforce platform with unaudited FY26 turnover of ₹3.69 Crore and a net loss of ₹2.09 Crore, while SIHL has no revenue and a net loss of ₹0.02 Crore. The investments are strategic but carry execution risk given Factrika's negative profitability and SIHL's zero revenue base.
- · Factrika was incorporated on July 2, 2024, and had no turnover in FY24; its FY25 audited turnover was ₹0.03 Crore.
- · SIHL has reported nil turnover for the last three fiscal years (FY24, FY25, FY26).
- · The second tranche in Factrika is conditional on performance milestones and is expected by March 31, 2027.
- · Info Edge's total investment commitment across both tranches is not fixed; the second tranche consideration will be determined later.
- · Post first tranche, Factrika will become a related party of Info Edge.
14-08-2026
Zensar Technologies has completed all requisite filings for the merger of its US-based step-down subsidiaries Bridgeview Life Sciences LLC and M3BI LLC with its material wholly-owned subsidiary Zensar Technologies Inc., USA. The M3BI LLC merger becomes effective September 1, 2026, following filings completed on August 13, 2026. This consolidation is part of Zensar's ongoing corporate restructuring, with post-merger filings still in process.
- · Merger of M3BI LLC with Zensar Technologies Inc. effective from September 1, 2026.
- · Filings for M3BI LLC merger completed on August 13, 2026.
- · Intimation received at 1:43 a.m. (IST) on August 14, 2026.
- · All requisite filings for both Bridgeview Life Sciences LLC and M3BI LLC mergers are now complete.
- · Certain post-merger and consequential filings remain under process.
14-08-2026
Rainbow Children's Medicare Limited has completed the acquisition of a 64% partnership interest in Super Prime Medical Care LLP on August 14, 2026, following the execution of a Partnership Interest and Contribution Transfer Agreement on July 29, 2026. The filing provides no financial details or performance metrics, so no positive or negative trends can be assessed.
- · The acquisition was completed on August 14, 2026, the same date as the filing.
- · The acquisition was made from the existing partners of Super Prime Medical Care LLP.
14-08-2026
20 Microns Limited has acquired a 99.99% partnership interest in M/s Shree Shrest Minerals, a Rajasthan-based partnership firm holding mining rights for Quartz and Feldspar, for a cash consideration of ₹1,50,00,000 (₹1.5 Crore). The acquisition is intended to strengthen the company's captive sourcing of industrial minerals and expand its mining operations. However, the target firm has been loss-making for the past two financial years, with a net loss of ₹3,01,205 in FY2025 and a declining turnover trend.
- · The target firm was registered on December 18, 2008, under the Indian Partnership Act, 1932.
- · The mining lease is located near Village Khakharmala, Tehsil Raipur, District Bhilwara, Rajasthan.
- · The acquisition is not a related party transaction; the transferors are not part of the promoter group.
- · Approval from the Registrar of Firms, Rajasthan, has been received for the reconstitution of the firm.
- · The acquisition is expected to be completed shortly, subject to customary closing formalities.
14-08-2026
NHPC Limited has published newspaper advertisements regarding the hearing date for the scheme of amalgamation of its wholly owned subsidiary, Jalpower Corporation Limited (JPCL), with itself. The hearing before the Ministry of Corporate Affairs (MCA) is scheduled for August 25, 2026. This is a procedural step in the merger process, which involves a wholly owned subsidiary and is not expected to have a material financial impact on NHPC.
- · The hearing is fixed for Tuesday, 25th August 2026 at 11:30 AM at the Ministry of Corporate Affairs, New Delhi.
- · Objections or support to the petition must be submitted to NHPC at least five days before the hearing.
- · The amalgamation is between NHPC and its wholly owned subsidiary, Jalpower Corporation Limited.
- · The newspaper clippings were published on August 14, 2026, in Business Standard, Financial Express, Jansatta, and Vaartha.
14-08-2026
Spandana Sphoorty Financial Limited's Board approved the amalgamation of its wholly owned subsidiary, Criss Financial Limited (CFL), into itself via a scheme of arrangement, aiming to reduce duplicity of costs, achieve revenue and cost synergies, and simplify the group structure. The Board also noted the resignation of nominee director Neeraj Swaroop (representing Kedaara Capital) and immediately appointed him as an Independent Director for a three-year term. The amalgamation is subject to NCLT, shareholder, creditor, and regulatory approvals, including from the RBI.
- · The amalgamation involves no cash consideration or share exchange ratio as CFL is a wholly owned subsidiary; all shares held by SSFL in CFL will be cancelled.
- · The pre- and post-amalgamation shareholding pattern of SSFL will remain unchanged.
- · Mr. Neeraj Swaroop's appointment as Independent Director is for a term of three consecutive years from August 14, 2026 to August 13, 2029, subject to shareholders' approval.
- · Mr. Swaroop has over 40 years of experience in FMCG and financial services, and holds degrees from IIT Delhi, IIM Ahmedabad, and the University of Virginia.
- · The Board meeting lasted from 3:10 PM to 3:40 PM on August 14, 2026.
14-08-2026
Sandur Manganese & Iron Ores Limited incorporated a wholly owned subsidiary, Royal Sandur Academy Private Limited, on August 14, 2026, to pursue academy-related businesses including coaching, sports, skill development, and educational infrastructure. The subsidiary was established with a subscription of 10,00,000 equity shares at ₹10 each, totaling ₹1,00,00,000, and is fully owned by the parent company. No financial performance data is available for this new entity, and no negative or flat metrics are present in the filing.
- · The subsidiary is incorporated in India and is a wholly owned subsidiary of Sandur Manganese & Iron Ores Limited.
- · The business of the subsidiary includes academy, coaching centers, sports academies, skill development, vocational training, educational infrastructure, digital learning platforms, residential facilities, and consultancy.
- · Approval for incorporation was received from the Ministry of Corporate Affairs, Government of India.
- · Consideration for the subsidiary is cash subscription of equity shares.
- · The subsidiary holds 100% shareholding by the parent company.
14-08-2026
Agribio Spirits Limited disclosed that the NCLT Jaipur Bench has ordered convening of meetings of equity shareholders, secured creditors, and unsecured creditors of both Agribiotech Industries Limited (Transferor) and Agribio Spirits Limited (Transferee) to consider the proposed Scheme of Amalgamation. The order marks a procedural step toward the merger, with further meeting details to be announced separately.
- · The NCLT order is dated August 13, 2026.
- · Meetings will be held for equity shareholders, secured creditors, and unsecured creditors of both companies.
- · Agribio Spirits Limited was formerly known as Beekay Niryat Limited.
14-08-2026
The Indian Card Clothing Company Limited approved its unaudited standalone and consolidated financial results for Q1 FY27 (quarter ended June 30, 2026). Standalone revenue from operations declined 5.4% YoY to ₹853.64 Lakh, while total income rose 14.9% YoY to ₹1,858.75 Lakh, driven by a 40.5% surge in other income. The company also approved a further investment of up to £250,000 in its wholly-owned subsidiary Garnett Wire Ltd., UK, to expand its international business. Additionally, CFO Sanjeevkumar Karkamkar resigned effective September 1, 2026, citing advancing age, but will continue as a Non-Executive Director.
- · Standalone total expenses for Q1 FY27 were ₹1,261.64 Lakh, down from ₹1,266.96 Lakh in Q1 FY26.
- · Garnett Wire Ltd. turnover history: FY2025-26 £826,760; FY2024-25 £781,435; FY2023-24 £738,701.
- · The investment in Garnett Wire Ltd. is a related party transaction as Mr. Mehul K. Trivedi, Deputy Chairman, is also a director of Garnett Wire Ltd.
- · The acquisition is expected to be completed within approximately 60 working days, subject to customary conditions.
- · The CFO resignation is effective September 1, 2026; he will continue as Non-Executive Non-Independent Director.
14-08-2026
Aster DM Healthcare Limited (now Aster DM Quality Care Limited) has received trading approval from NSE and BSE for 35,35,51,410 equity shares of ₹10 each allotted to eligible shareholders of Quality Care India Limited under a Scheme of Amalgamation. The shares will be listed and available for trading from August 17, 2026. This marks a key milestone in the merger between Aster DM and Quality Care India (operator of CARE Hospitals and Evercare brands).
- · The equity shares have distinctive numbers ranging from 523835315 to 877386724.
- · The record date for allotment was July 9, 2026.
- · The company's name has been changed to Aster DM Quality Care Limited.
- · The trading approval was granted on August 14, 2026, with trading commencing August 17, 2026.
14-08-2026
The National Company Law Tribunal (NCLT), Mumbai Bench, has approved the Scheme of Merger by Absorption of GB Global Limited (Transferor Company) into Dev Land and Housing Private Limited (Transferee Company). The appointed date for the merger is April 1, 2024. Under the scheme, eligible shareholders of GB Global (other than the transferee company) will receive a cash payment of ₹120 per equity share (face value ₹10) and 1 redeemable preference share (face value ₹10, 0.01% dividend, 10-year tenure) for each equity share held, based on a registered valuer's valuation of ₹78.94 per share. The merger aims to reduce compliance costs, streamline operations, and provide an exit to shareholders, while the equity shares of GB Global, which have been suspended from trading since June 3, 2021, will be deemed delisted.
- · GB Global's equity shares have been suspended from trading on BSE and NSE since June 3, 2021.
- · The Transferor Company (GB Global) is a subsidiary of the Transferee Company (Dev Land and Housing Private Limited); hence no consideration is payable for shares held by the transferee company, and those shares will be cancelled.
- · The redeemable preference shares (RPS) have a tenure of ten years from allotment and are redeemable at face value.
- · The NCLT order was pronounced on August 12, 2026, and the company received a copy on August 14, 2026.
- · The Board of Directors of both companies approved and amended the scheme multiple times between February and August 2025.
- · The scheme is intended to revive the Transferor Company, which faces procedural and technical difficulties in implementing its resolution plan with stock exchanges.
- · No consideration is payable to the Transferee Company for its own holdings in the Transferor Company.
14-08-2026
Orchid Pharma Limited's Board approved revised audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, reflecting the amalgamation of Dhanuka Laboratories Limited (effective July 10, 2026, with appointed date April 1, 2024). On a standalone basis, the company reported a Q4 FY26 profit of ₹3,266.29 Lakh, a significant improvement from a loss of ₹254.55 Lakh in Q3 FY26, but a decline from ₹3,959.66 Lakh in Q4 FY25. For the full year FY26, standalone profit fell sharply to ₹3,462.00 Lakh from ₹14,189.71 Lakh in FY25, a 75.6% decline. Consolidated results show a similar trend: Q4 FY26 profit of ₹2,583.94 Lakh versus a loss of ₹928.97 Lakh in Q3 FY26, but down from ₹3,404.25 Lakh in Q4 FY25; full-year consolidated profit dropped to ₹995.91 Lakh from ₹13,507.05 Lakh in FY25, a 92.6% decline.
- · The amalgamation of Dhanuka Laboratories Limited into Orchid Pharma was sanctioned by NCLT Chennai and became effective July 10, 2026, with appointed date April 1, 2024.
- · Statutory auditors (Singhi & Co.) issued an unmodified opinion on revised standalone results but a modified opinion on revised consolidated results.
- · Standalone other equity increased to ₹1,58,679.07 Lakh as at March 31, 2026 from ₹1,55,085.30 Lakh as at March 31, 2025.
- · Consolidated total assets grew to ₹2,25,842.77 Lakh as at March 31, 2026 from ₹2,07,736.55 Lakh as at March 31, 2025.
- · Consolidated borrowings (non-current) increased to ₹18,473.70 Lakh as at March 31, 2026 from nil as at March 31, 2025.
- · Standalone cash and cash equivalents dropped sharply to ₹130.46 Lakh as at March 31, 2026 from ₹1,594.17 Lakh as at March 31, 2025.
- · Exceptional items of ₹22.02 Lakh (standalone) and ₹733.29 Lakh (consolidated) were recorded in FY26, compared to nil in FY25.
14-08-2026
Jupiter Infomedia Limited (now Arix Energix Limited) announced its unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, and approved a draft Scheme of Arrangement to proportionately distribute shares of its wholly owned subsidiary Jineshvar Securities Private Limited to its shareholders. The Board also approved the incorporation of a wholly owned subsidiary in the UAE, Arix Metals Trading FZCO, with a paid-up capital of AED 1,00,000. The financial results show the subsidiary Jineshvar Securities Private Limited contributed total revenues of Rs. 24.72 lakh and net profit of Rs. 16.68 lakh for the quarter.
- · The company's name changed from Jupiter Infomedia Limited to Arix Energix Limited effective July 17, 2026, pursuant to a special resolution passed on June 24, 2026.
- · The Scheme of Arrangement will result in Jineshvar Securities Private Limited ceasing to be a wholly owned subsidiary of Jupiter Infomedia Limited.
- · The proposed UAE subsidiary will be engaged in Metal Scrap Trading and is expected to be incorporated within 15 to 30 days.
- · The Board meeting commenced at 05:15 PM IST and concluded at 06:00 PM IST on August 14, 2026.
14-08-2026
Physicswallah Limited (PWL) has approved the acquisition of the remaining 10% stake in Bharat Innovations Global Private Limited (BIGPL) from NSDC International Limited, increasing its shareholding from 90% to 100% and making BIGPL a wholly owned subsidiary. The acquisition involves no cash consideration and is expected to close within six months. BIGPL, an education company incorporated in November 2024, has minimal turnover (₹0.16 Cr in FY 2025-26) and a negative net worth of ₹(66,90,740).
- · BIGPL was incorporated on November 26, 2024.
- · BIGPL's turnover for FY 2024-25 was ₹0.00 and for FY 2023-24 was not applicable.
- · The acquisition is not a related party transaction.
- · No governmental or regulatory approvals are required for the acquisition.
- · The Board meeting commenced at 02:30 PM IST and concluded at 04:50 PM IST on August 14, 2026.
14-08-2026
Race Eco Chain Limited has invested INR 1,02,00,000 (Rupees One Crore Two Lakh) in its subsidiary Ganesha Recycling Chain Private Limited via a rights issue subscription, receiving 1,02,000 equity shares. The investment maintains Race Eco Chain's existing 51% ownership stake in the subsidiary. Ganesha Recycling Chain, incorporated on September 10, 2024, reported a turnover of 0.01 Lakh in 2025 and 21.19 Lakh in 2026, showing significant growth from a very low base.
- · The transaction is classified as a related party transaction as Ganesha Recycling Chain is a subsidiary, but it was conducted at arm's length basis.
- · No promoter/promoter group/group companies have any interest in the entity.
- · The investment is part of the company's overall corporate objective to expand its recycling business.
- · No governmental or regulatory approvals were required for the acquisition.
- · Ganesha Recycling Chain Private Limited was incorporated on September 10, 2024, and is engaged in the recycling business in India.
14-08-2026
Gufic Biosciences Limited's Board approved the incorporation of a wholly-owned subsidiary in the Philippines, Gufic Philippines Inc., with an investment of up to USD 250,000 (approx. ₹2.08 Cr) via cash subscription to equity shares. The subsidiary will handle marketing, distribution, and IP management of the company's pharmaceutical products, expanding Gufic's presence in the Philippines. The incorporation is subject to regulatory approvals in both India and the Philippines and is expected to be completed within 12 months.
- · Board meeting held on August 14, 2026, from 5:00 p.m. to 6:10 p.m.
- · Subsidiary to be incorporated within 12 months, subject to statutory and regulatory formalities.
- · Balance equity (approx. 0.01%) will be held by directors of the proposed subsidiary as per Philippine law.
- · Investment will be in cash, up to USD 250,000 or equivalent in Philippine Peso.
14-08-2026
Parmax Pharma Limited has undergone a significant change in control as Acquirers and Persons Acting in Concert (PACs) acquired 11,52,450 equity shares (30.81% of total equity) on August 13, 2026, pursuant to a Share Purchase Agreement dated June 8, 2026. The acquisition increased the combined shareholding of the acquirer group from 27.20% to 58.01%, giving them majority control. The purchase price was ₹35.00 per share, and the shares are yet to be credited to demat accounts.
- · The acquisition was executed off-market via a Share Purchase Agreement dated June 8, 2026.
- · The sellers were Alkesh Mahasukhlal Gopani, Vipul Mahasukhlal Gopani, and Pravina Mahasukh Gopani.
- · The shares acquired are yet to be credited to the respective demat accounts of the acquirers and PACs.
- · The disclosure was made under Regulation 18(6) of SEBI (SAST) Regulations, 2011, which requires reporting of acquisitions during the offer period.
- · The public announcement was made on June 8, 2026, with detailed public statement on June 15, 2026, and Letter of Offer on July 21, 2026.
14-08-2026
Adani Energy Solutions Limited (AESL) has executed a Share Purchase Agreement (SPA) on August 14, 2026, to acquire 100% equity shares of Vizag Power Transmission Limited (VPTL) from REC Power Development and Consultancy Limited (RECPDCL) for cash consideration at a face value of Rs. 10 per share. The acquisition is linked to AESL's previously announced ~Rs 8,500 crore transmission project in Andhra Pradesh and is intended to support power supply to proposed Green Hydrogen/Green Ammonia projects in the Vizag area, catering to an estimated demand of around 4,500 MW. VPTL, incorporated on February 16, 2026, has an authorized and paid-up share capital of Rs. 5 Lakh each, with no turnover history.
- · The acquisition is not a related party transaction.
- · The target entity, VPTL, is in the Electric Utilities (Transmission Service Provider) industry.
- · No governmental or regulatory approvals are required for the acquisition.
- · The acquisition has been completed as of the filing date.
Get daily alerts with 10 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 19 filings
₹500/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: India Sector Consolidation Regulatory Filings
August 12, 2026
India Sector Consolidation Regulatory Filings — August 12, 2026
August 11, 2026
India Sector Consolidation Regulatory Filings — August 11, 2026
August 10, 2026
India Sector Consolidation Regulatory Filings — August 10, 2026
August 08, 2026
India Sector Consolidation Regulatory Filings — August 08, 2026
🇮🇳 More from India
View all →August 15, 2026
India Pre-Market Regulatory Roundup — August 15, 2026
India Pre-Market Regulatory Roundup
August 15, 2026
India Merger Acquisition MCA Regulatory Filings — August 15, 2026
India Merger Acquisition MCA Regulatory Filings
August 14, 2026
India Upcoming Corporate Actions BSE NSE — August 14, 2026
India Upcoming Corporate Actions BSE NSE
August 14, 2026
India Quarterly Results BSE NSE Announcements — August 14, 2026
India Quarterly Results BSE NSE Announcements